Camden Capital, LLC Insulet Corp Transaction History

Camden Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$127.77 - $221.42 $126,236 - $218,762	988 New	988 $214,000
Q2 2023 Aug 09, 2023	SELL	$272.48 - $330.23 $19,618 - $23,776	-72 Reduced 7.02%	953 $274,000
Q1 2023 May 11, 2023	SELL	$276.36 - $326.03 $63,010 - $74,334	-228 Reduced 18.2%	1,025 $326,000
Q4 2022 Feb 13, 2023	BUY	$212.22 - $313.46 $67,485 - $99,680	318 Added 34.01%	1,253 $368,000
Q3 2022 Nov 08, 2022	SELL	$224.6 - $281.45 $2,470 - $3,095	-11 Reduced 1.16%	935 $214,000

Q1 2022 May 06, 2022	BUY	$194.8 - $275.7 $184,280 - $260,812	946 New	946 $252,000

613

62.9M

339K

916K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $13.7B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Camden Capital, LLC with notifications on news.